CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 8-K Event Regulation FD disclosure
- 424B3 Offering Prospectus
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- CT ORDER Other Confidential Order
- EFFECT Other Notice of Effectiveness
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Other events
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- UPLOAD Other SEC-generated Letter
- CT ORDER Other Confidential Order
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K/A Event Material agreement · Acquisition or sale completed · Unregistered share sale · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Shell status change
- 8-K Event Agreement ended · Code of ethics change · Other events
Page 46 of 50 · 1,000 filings